Product Manual

Page 9 of 77QuickVue+ Infectious Mononucleosis test
FOR INFORMATIONAL USE ONLY
FOR INFORMATIONAL USE ONLY
Not to be used for performing assay. Refer to most current package insert accompanying your test kit.
LIMItAtIOns
1. As is the case of any other diagnostic procedure, the results obtained by this kit yield
data that must be used in addition to other information available to the physician.
2. QuickVue+ Infectious Mononucleosis test is a qualitative test for the detection of IM
heterophile antibodies.
3. A negative result may be obtained from patients at the onset of the disease due to
antibody concentration below the sensitivity of this test kit. If symptoms persist or
increase in intensity, the test should be repeated.
4. Some segments of the population who contract Infectious Mononucleosis do not
produce measurable levels of heterophile antibodies. Approximately 50% of children
under 4 years of age who have IM may test as IM heterophile antibody negative.
4
PeRFORMAnCe CHARACteRIstICs
QuickVue+ Infectious Mononucleosis test was compared to two other commercially
available test kits: an EIA, and a slide hemagglutination test. The results obtained using
QuickVue+ Infectious Mononucleosis test were substantially equivalent to the results
obtained using these other tests and are summarized below.
Table 1: In this study, a total of 511 serum, plasma and whole blood samples were tested
using QuickVue+ Infectious Mononucleosis test and a commercially available EIA.
Of the 511 samples, 74 were found to be positive by EIA and also positive by the
QuickVue+ Infectious Mononucleosis test; similarly, 437 were found to be negative by
EIA and 436 were also negative by the QuickVue+ Infectious Mononucleosis test.
Based on this data, specificity was 99.8% (436/437), and sensitivity was >99.9% (74/74).
Overall agreement was 99.8% (510/511).
QuickVue+ IM Positive
QuickVue+ IM Negative
TOTAL
EIA
Positive
EIA
Negative
74
0
74
1
436
437